Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Watchmaker Genomics develops precision-engineered enzymes and reagents that power next-generation sequencing (NGS) and advanced molecular biology applications. Their products are designed to improve sensitivity and streamline workflows in genomics research areas such as rare variant detection, ctDNA analysis, transcriptomics, epigenetics, single-cell assays, pathogen surveillance, and more. The company’s vertically integrated platform leverages computational biology with protein engineering to create high-performance solutions for reading/writing/editing DNA/RNA. They have achieved ISO 13485 certification for their quality management system supporting medical research reagent manufacturing. Recent partnerships include collaborations with Factorial Biotechnologies on single-cell sequencing simplification and Element Biosciences on NGS library preparation validation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Watchmaker Genomics.